| Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein AC Walls, YJ Park, MA Tortorici, A Wall, AT McGuire, D Veesler Cell 181 (2), 281-292. e6, 2020 | 9923 | 2020 |
| Rational HIV immunogen design to target specific germline B cell receptors J Jardine, JP Julien, S Menis, T Ota, O Kalyuzhniy, A McGuire, D Sok, ... Science 340 (6133), 711-716, 2013 | 790 | 2013 |
| mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection L Stamatatos, J Czartoski, YH Wan, LJ Homad, V Rubin, H Glantz, ... Science 372 (6549), 1413-1418, 2021 | 537 | 2021 |
| Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation E Seydoux, LJ Homad, AJ MacCamy, KR Parks, NK Hurlburt, ... Immunity 53 (1), 98-105. e5, 2020 | 388 | 2020 |
| Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies AT McGuire, S Hoot, AM Dreyer, A Lippy, A Stuart, KW Cohen, J Jardine, ... Journal of Experimental Medicine 210 (4), 655-663, 2013 | 342 | 2013 |
| Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice P Dosenovic, L von Boehmer, A Escolano, J Jardine, NT Freund, AD Gitlin, ... Cell 161 (7), 1505-1515, 2015 | 291 | 2015 |
| Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study KM Hastie, H Li, D Bedinger, SL Schendel, SM Dennison, K Li, ... Science 374 (6566), 472-478, 2021 | 246 | 2021 |
| Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs S Hoot, AT McGuire, KW Cohen, RK Strong, L Hangartner, F Klein, ... PLoS pathogens 9 (1), e1003106, 2013 | 223 | 2013 |
| Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires M Tian, C Cheng, X Chen, H Duan, HL Cheng, M Dao, Z Sheng, M Kimble, ... Cell 166 (6), 1471-1484. e18, 2016 | 214 | 2016 |
| Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation NK Hurlburt, E Seydoux, YH Wan, VV Edara, AB Stuart, J Feng, ... Nature communications 11 (1), 5413, 2020 | 186 | 2020 |
| Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice AT McGuire, MD Gray, P Dosenovic, AD Gitlin, NT Freund, J Petersen, ... Nature communications 7 (1), 10618, 2016 | 184 | 2016 |
| Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy I Ullah, J Prévost, MS Ladinsky, H Stone, M Lu, SP Anand, ... Immunity 54 (9), 2143-2158. e15, 2021 | 164 | 2021 |
| A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Cell host & microbe 29 (7), 1137-1150. e6, 2021 | 159 | 2021 |
| Structural basis for broad coronavirus neutralization MM Sauer, MA Tortorici, YJ Park, AC Walls, L Homad, OJ Acton, ... Nature structural & molecular biology 28 (6), 478-486, 2021 | 155 | 2021 |
| Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo M Medina-Ramírez, F Garces, A Escolano, P Skog, SW de Taeye, ... Journal of Experimental Medicine 214 (9), 2573-2590, 2017 | 153 | 2017 |
| Glycan shield and fusion activation of a deltacoronavirus spike glycoprotein fine-tuned for enteric infections X Xiong, MA Tortorici, J Snijder, C Yoshioka, AC Walls, W Li, AT McGuire, ... Journal of virology 92 (4), 10.1128/jvi. 01628-17, 2018 | 143 | 2018 |
| Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques A Escolano, HB Gristick, ME Abernathy, J Merkenschlager, R Gautam, ... Nature 570 (7762), 468-473, 2019 | 141 | 2019 |
| Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies AT McGuire, AM Dreyer, S Carbonetti, A Lippy, J Glenn, JF Scheid, ... Science 346 (6215), 1380-1383, 2014 | 133 | 2014 |
| Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A viruses Y Avnir, AS Tallarico, Q Zhu, AS Bennett, G Connelly, J Sheehan, J Sui, ... PLoS pathogens 10 (5), e1004103, 2014 | 128 | 2014 |
| Germline‐targeting immunogens L Stamatatos, M Pancera, AT McGuire Immunological reviews 275 (1), 203-216, 2017 | 117 | 2017 |
Leonidas StamatatosFred Hutchinson Cancer Research CenterVerified email at fredhutch.org
